161 related articles for article (PubMed ID: 34285335)
1. Loss of Acot12 contributes to NAFLD independent of lipolysis of adipose tissue.
Park S; Song J; Baek IJ; Jang KY; Han CY; Jun DW; Kim PK; Raught B; Jin EJ
Exp Mol Med; 2021 Jul; 53(7):1159-1169. PubMed ID: 34285335
[TBL] [Abstract][Full Text] [Related]
2. PPARα-ACOT12 axis is responsible for maintaining cartilage homeostasis through modulating de novo lipogenesis.
Park S; Baek IJ; Ryu JH; Chun CH; Jin EJ
Nat Commun; 2022 Jan; 13(1):3. PubMed ID: 34987154
[TBL] [Abstract][Full Text] [Related]
3. Acyl-Coenzyme A Thioesterase 9 Traffics Mitochondrial Short-Chain Fatty Acids Toward De Novo Lipogenesis and Glucose Production in the Liver.
Steensels S; Qiao J; Zhang Y; Maner-Smith KM; Kika N; Holman CD; Corey KE; Bracken WC; Ortlund EA; Ersoy BA
Hepatology; 2020 Sep; 72(3):857-872. PubMed ID: 32498134
[TBL] [Abstract][Full Text] [Related]
4. ACOT12-Dependent Alteration of Acetyl-CoA Drives Hepatocellular Carcinoma Metastasis by Epigenetic Induction of Epithelial-Mesenchymal Transition.
Lu M; Zhu WW; Wang X; Tang JJ; Zhang KL; Yu GY; Shao WQ; Lin ZF; Wang SH; Lu L; Zhou J; Wang LX; Jia HL; Dong QZ; Chen JH; Lu JQ; Qin LX
Cell Metab; 2019 Apr; 29(4):886-900.e5. PubMed ID: 30661930
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-CoA Deficiency Is Involved in the Regulation of Iron Overload on Lipid Metabolism in Apolipoprotein E Knockout Mice.
Luo G; Xiang L; Xiao L
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956917
[TBL] [Abstract][Full Text] [Related]
6. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
Lee H; Ahn J; Shin SS; Yoon M
Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077
[TBL] [Abstract][Full Text] [Related]
7. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H
Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function.
Wang X; Wang J; Ying C; Xing Y; Su X; Men K
BMC Pharmacol Toxicol; 2024 Jan; 25(1):7. PubMed ID: 38173037
[TBL] [Abstract][Full Text] [Related]
9. Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease.
Park H; Liu Y; Kim HS; Shin JH
Nutr Res; 2016 Jan; 36(1):57-64. PubMed ID: 26773781
[TBL] [Abstract][Full Text] [Related]
10. Niacin Ameliorates Hepatic Steatosis by Inhibiting De Novo Lipogenesis Via a GPR109A-Mediated PKC-ERK1/2-AMPK Signaling Pathway in C57BL/6 Mice Fed a High-Fat Diet.
Ye L; Cao Z; Lai X; Shi Y; Zhou N
J Nutr; 2020 Apr; 150(4):672-684. PubMed ID: 31858105
[TBL] [Abstract][Full Text] [Related]
11. PPARα is one of the key targets for dendrobine to improve hepatic steatosis in NAFLD.
Xu Y; Wang M; Luo Y; Liu H; Ling H; He Y; Lu Y
J Ethnopharmacol; 2024 Apr; 323():117684. PubMed ID: 38171466
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D Deficiency Increases Lipogenesis and Reduces Beta-Oxidation in the Liver of Diet-Induced Obese Mice.
Borges CC; Salles AF; Bringhenti I; Mandarim-DE-Lacerda CA; Aguila MB
J Nutr Sci Vitaminol (Tokyo); 2018; 64(2):106-115. PubMed ID: 29710028
[TBL] [Abstract][Full Text] [Related]
13. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
[TBL] [Abstract][Full Text] [Related]
14. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into GDP-mediated regulation of a bacterial acyl-CoA thioesterase.
Khandokar YB; Srivastava P; Cowieson N; Sarker S; Aragao D; Das S; Smith KM; Raidal SR; Forwood JK
J Biol Chem; 2017 Dec; 292(50):20461-20471. PubMed ID: 28972175
[TBL] [Abstract][Full Text] [Related]
16. Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway.
Chen K; Chen X; Xue H; Zhang P; Fang W; Chen X; Ling W
Food Funct; 2019 Feb; 10(2):814-823. PubMed ID: 30675881
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic and transcriptional regulation of the cytoplasmic acetyl-CoA hydrolase ACOT12.
Horibata Y; Ando H; Itoh M; Sugimoto H
J Lipid Res; 2013 Aug; 54(8):2049-2059. PubMed ID: 23709691
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
19. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
20. PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease.
Huang K; Du M; Tan X; Yang L; Li X; Jiang Y; Wang C; Zhang F; Zhu F; Cheng M; Yang Q; Yu L; Wang L; Huang D; Huang K
J Hepatol; 2017 May; 66(5):962-977. PubMed ID: 27979751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
